Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...

While Eli Lilly is rethinking its biotech incubator plans in Europe, the Big Pharma has gone ahead and opened its San Diego site. The Gateway Labs are co-working spaces for researchers that also act ...

Eli Lilly has won the second FDA approval for an oral selective estrogen receptor degrader (SERD). Like the first oral SERD, Lilly’s imlunestrant is only cleared to treat ER-positive, HER2-negative ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 5.5% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the ...

Sept. 23 (UPI) --Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000 construction workers in the greater Houston area.

Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab has halted a study of an experimental drug, designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, ...

KPRC 2 first reported earlier this month that documents filed with the Texas Comptroller’s Office outlined the company’s plans. The facility is expected to create 4,000 construction jobs and 615 ...

The pharmaceutical company Eli Lilly announced on Tuesday that it will build a $6.5 billion facility in Texas, marking the company’s second multibillion-dollar U.S. investment this month. The ...

Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...

Eli Lilly And Company (NYSE:LLY) shares are trading higher Wednesday after President Donald Trump recently announced a deal with Pfizer as well as the ‘TrumpRx’ site to decrease prices. What To Know: ...

SHANGHAI, Sept 23 (Reuters) - Innovent Biologics' (1801.HK), opens new tab newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals ...

Pharmaceutical giant Eli Lilly unveiled plans to build a $6.5 billion biomanufacturing plant in northeast Houston within the next five years, bolstering the region’s bid to become a national ...